Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-25 @ 11:21 PM
NCT ID: NCT00488293
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00488293
Study Brief: Impact of Teledermatology on Health Services Outcomes in the Department of Veterans Affairs
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Conventional Referrals Conventional consult process Conventional consult process: Standard electronic consult None None 1 196 2 196 View
Teledermatology Referrals Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set None None 2 196 1 196 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Death Unrelated to Study Participation SYSTEMATIC_ASSESSMENT General disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Wound Dehiscence SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Rash from Sunscreen SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Infection at Biopsy Site SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View